US FDA approves higher dose of Regeneron's eye disease drug Eylea
(Reuters) -The U.S. Food and Drug Administration approved a higher dose version of Regeneron Pharmaceuticals' drug Eylea for treatment of
2023-08-19 07:50
US FDA approves Regeneron's ultra-rare blood disease drug
(Reuters) -Regeneron Pharmaceuticals said on Friday the U.S. health regulator approved its drug to treat a rare blood disease. The
2023-08-19 02:24
US FDA declines to approve Regeneron high-dose Eylea
The U.S. Food and Drug Administration on Tuesday declined to approve a higher-dose version of Regeneron Pharmaceuticals' blockbuster
2023-06-28 02:55